A patient-friendly, evidence-based guide to AS and axial spondyloarthritis treatment in 2026: NSAIDs, biologics, IL-17 inhibitors, JAK inhibitors, biosimilars, switching, safety checks, and the questions to bring your rheumatologist.
If you're reading this, there's a good chance you or someone you love has been diagnosed with ankylosing spondylitis. Maybe you're sitting in a waiting room. Maybe you've just been handed a prescription with a name you can't pronounce. Maybe you've been on three drugs already and you're trying to figure out what comes next.
Sign in or create a free account
A free reader account lets you read two articles a day, save pieces for later, and join the conversation.